CEDS and Ongoing Treatment
Chronic Endocannabinoid Deficiency Syndrome (CEDS) has broad effects on health. Not only does this mean CEDS can be an underlying cause of many symptoms, it diminishes the effects of other treatments. Treating CEDS is a collaborative effort across medical disciplines. This is why repetitive failed treatments is a common symptom of CEDS.
CEDS, Opiates and Safety
Many people undergoing opiate treatment exhibit the symptoms of CEDS. While this therapy will treat symptoms, CEDS may persist as an underlying cause, diminishing the effect of other treatments.
The opioid crisis is driven by a high toxicity to therapeutic ratio, such that there is a risk of unexpected and sudden death. Alternative solutions such as cannabinoids, have the distinct advantage of their safety profile. Cannabinoids do not affect the medulla respiratory centre (the breathing centre of the brain), so, unlike many other alternatives, it is much less dangerous. Although no reported cases of death from “overdose” on cannabinoids exist, experts estimate it to be measured in thousands, compared to most medication that is measured in tens; meaning it is far safer than many alternatives.